Home›Companies›Biotech & Pharma›ADARx Pharmaceuticals

ADARx Pharmaceuticals, Inc.

Updated Oct 27, 2026·Latest SEC filing Aug 10, 2023·Suggest an edit

About ADARx Pharmaceuticals

ADARx Pharmaceuticals is a private company based in San Diego, California, incorporated in 2019 in Delaware. It has reported $352,500,005 raised in seven offerings on Form D since February 2020. Its chief executive is Zhen Li.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Aug 2, 2023Aug 10, 2023$200,000,012fully sold28$7.1MEquityRule 506(b)Form D ↗
Jan 26, 2023Jan 26, 2023$45,999,999fully sold10$4.5MEquityRule 506(b)Form D ↗
Jul 30, 2021Aug 17, 2021$74,999,996fully sold6$12.4MEquityRule 506(b)Form D ↗
May 14, 2021May 24, 2021$15,499,998fully sold3$5.1MEquityRule 506(b)Form D ↗
Nov 4, 2020Nov 17, 2020$6,000,000fully sold3$2.0MEquityRule 506(b)Form D ↗
Jul 24, 2020Aug 7, 2020$5,000,000fully sold3$1.6MEquityRule 506(b)Form D ↗
Jan 24, 2020Feb 6, 2020$5,000,000fully sold3$1.6MDebt, Options, Securities on exerciseRule 506(b)Form D ↗
Total, seven offerings$352,500,005

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on ADARx Pharmaceuticals's Form D filed Aug 10, 2023.

RZ
Rui Zhu
Executive officer
SG
Simeon George
Director
Also a director at Avenzo Therapeutics and Rezo Therapeutics.
JL
Judith Li
Director
Also a director at Avenzo Therapeutics.
Erez Chimovits
Erez Chimovits
Director
Also a director at Capstan Therapeutics and ImmPACT Bio USA, a senior managing director at orbimed at Fore Biotherapeutics and an executive officer at OrbiMed Partners.
SG
ZL
Zhen Li
President and Chief Executive Officer, director
CY
Chen Yu
Director
RS
Ricky Sun
Director
LK
Lorence Kim
Director

Earlier filings also listed Xiong Zhang (director, last listed Aug 2021) and Hongbo Lu (director, last listed Nov 2020).

Sources

  1. SECADARx Pharmaceuticals, Inc. filing history